Financial statements Biolive Innovation

Balance sheet of Biolive Innovation

Company age:
Age:
10 y. 1 m. 11 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOLIVE INNOVATION

Year
2018
2020
2021
2022
2023
Total assets 2 852 851,31 500 572,06 3 974 409,86 1 701 903,72 3 393 274,96
A. Fixed assets 2 193 143,40 4 660 914,80 3 485 212,64 1 059 933,76 3 266 753,33
B. Current assets 659 707,91 339 657,26 489 197,22 641 969,96 126 521,63
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 2 852 851,31 5 000 572,06 3 974 409,86 1 701 903,72 3 393 274,96
A. Equity 94 680,16 413 046,04 133 456,34 56 309,79 199 888,47
B. Liabilities and provisions for liabilities 2 758 171,15 4 587 526,02 3 840 953,52 1 645 593,93 3 193 386,49
I. Long-term liabilities 283 984,83 141 089,29 141 089,29 141 089,29 0,00
II. Short-term liabilities 792 948,52 1 556 542,75 1 214 159,67 636 324,98 656 763,41
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.